These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26666150)

  • 41. [Treatment recommendations for various stages in diabetic nephropathy].
    Takane H; Suzuki H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():379-83. PubMed ID: 15999738
    [No Abstract]   [Full Text] [Related]  

  • 42. Updating the natural history of diabetic nephropathy.
    Pugliese G
    Acta Diabetol; 2014 Dec; 51(6):905-15. PubMed ID: 25297841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
    Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy.
    Furukawa M; Gohda T; Tanimoto M; Tomino Y
    ScientificWorldJournal; 2013; 2013():928197. PubMed ID: 23737732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
    Samsu N
    Biomed Res Int; 2021; 2021():1497449. PubMed ID: 34307650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Diabetic Nephropathy in Patients Attending the Endocrine Department of Mymensingh Medical College Hospital.
    Islam MR; Sultana N; Sutradhar SR; Asaduzzaman M
    Mymensingh Med J; 2020 Jul; 29(3):530-538. PubMed ID: 32844790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives.
    Rossing P; Persson F; Frimodt-Møller M
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S31-S37. PubMed ID: 29606261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
    Alicic RZ; Rooney MT; Tuttle KR
    Clin J Am Soc Nephrol; 2017 Dec; 12(12):2032-2045. PubMed ID: 28522654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Managing diabetic kidney disease].
    Alder H; Ambühl PM
    Ther Umsch; 2020 Sep; 77(7):333-338. PubMed ID: 32996426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
    Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
    J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic nephropathy-pathophysiology and management.
    Shumway JT; Gambert SR
    Int Urol Nephrol; 2002; 34(2):257-64. PubMed ID: 12775108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and Management of Diabetic Nephropathy in Western Countries.
    Satirapoj B; Adler SG
    Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diabetic nephropathy and cardiac disease].
    Gross JL; Silveiro SP; Canani LH; Friedman R; Leitão CB; Azevedo MJ
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):244-56. PubMed ID: 17505631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on the management of nephropathy in type 2 diabetes.
    Zhao HL; Thomas GN; Leung W; Tomlinson B; Hsu YH; Chan P
    J Chin Med Assoc; 2003 Nov; 66(11):627-36. PubMed ID: 14768849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.